Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetoacetic Acid SCHEMBL29155554 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL648595 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL491475 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL5795622 | 0.89 | TGFBR1 (0.40) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Glycerin SCHEMBL28122415 | 0.89 | KDM4E (0.46) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL2005043 | 0.89 | KDM4E (0.37) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Glycerin SCHEMBL28686701 | 0.87 | ALDH1A1 (0.53) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL27153879 | 0.87 | THRB (0.54) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL28640192 | 0.85 | TDP1 (0.50) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL1058961 | 0.85 | TDP1 (0.50) | LMNAALDH1A1KDM4EKDM6BKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113966323-B | Method for producing ketocarboxylic acid polyol-based esters | 凯托利皮克斯治疗有限责任公司 | 2023-11-28 | — | — | CN | claimed |
| CN-114008015-A | Process for preparing polyol esters of hydroxycarboxylic acids, in particular polyglycerol esters | IOI油脂化学品有限责任公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113966323-A | Method for producing ketocarboxylic acid polyol ester | IOI油脂化学品有限责任公司 | 2022-01-21 | — | — | CN | claimed |
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | TODAY, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12286534-B2 | Binder for an aqueous coating composition | ALLNEX AUSTRIA GMBH (AT) | 2025-04-29 | — | — | US | disclosed |
| US-20240425643-A1 | FOAM COMPOSITIONS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2024-12-26 | — | — | US | disclosed |
| US-12098240-B2 | Foam compositions | HOLCIM TECHNOLOGY LTD (CH) | 2024-09-24 | — | — | US | disclosed |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | TODAY, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | Today Inc. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-114008015-B | Process for the preparation of polyhydric alcohol esters of hydroxycarboxylic acids, in particular polyglycerol esters | 凯托利皮克斯治疗有限责任公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20050004155-A1 | Use of methylnaltrexone to treat irritable bowel syndrome | PROGENICS PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | disclosed |
| US-20040259899-A1 | Combination therapy for constipation | PROGENICS PHARMACEUTICALS, INC. | 2004-12-23 | — | — | US | disclosed |
| WO-2004091622-A1 | THE USE OF PERIPHERAL OPIOIS ANTAGONISTS, ESPECIALLY METHYLNALTREXONE TO TREAT IRRITABLE BOWEL SYNDROME | PROGENICS PHARMACEUTICALS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004091665-A1 | COMBINATION THERAPY FOR CONSTIPATION COMPRISING A LAXATIVE AND A PERIPHERAL OPIOID ANTAGONIST | PROGENICS PHARMACEUTICALS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| CN-1316902-A | Therapeutic compositions (II) | BTG INT LTD (GB) | 2001-10-10 | — | — | CN | disclosed |
| US-4970143-A | BICARBONATE BUFFER SOLUTION | NESTEC S.A. (CH) | 1990-11-13 | — | — | US | disclosed |
| EP-0037943-B1 | PHARMACEUTICAL COMPOSITION FOR INTRARECTAL ADMINISTRATION, AND SUPPOSITORY PREPARED THEREFROM | TEIJIN LIMITED (JP) | 1985-08-14 | — | — | EP | disclosed |
| US-4434159-A | PEPTIDE HORMONES, POLYSACCHARIDES, ABSORPTION AIDS | TEIJIN LIMITED (JP) | 1984-02-28 | — | — | US | disclosed |
| EP-0037943-A2 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom | TEIJIN LIMITED (JP) | 1981-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | SLC2A9, GYS1, SLC2A8 | LMNA 3333/4885ALDH1A1 350/4885KDM4E 1504/4885 |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | LMNA 1973/4885ALDH1A1 1249/4885KDM4E 3282/4885 |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | CPT1B, GK, CPT1A | LMNA 1973/4885ALDH1A1 1249/4885KDM4E 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.